Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid

Saved in:

Bibliographic Details
Main Authors:	Kyohei Shibuta, Koremasa Hayama, Katsuhiro Miura, Hideki Fujita
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Journal of Cutaneous Immunology and Allergy
Subjects:	pyoderma gangrenosum myelofibrosis adalimumab ruxolitinib Janus Kinase 2
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14079/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

PASS Syndrome: Clinical Observation
by: Olga Valentinovna Grabovskaya, et al.
Published: (2025-01-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
by: Mariarita Spampinato, et al.
Published: (2025-01-01)

Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome
by: Sofia Miranda, et al.
Published: (2025-01-01)

Tuberculosis of the tongue in a patient under treatment with adalimumab
by: Cintia Mussi Milani, et al.
Published: (2024-12-01)

Analysis of MicroRNA -155-5p Expression in Patients with Primary Myelofibrosis.
by: Sarah I. Khaleel, et al.
Published: (2024-12-01)

The global, regional, and national patterns of change in the burden of bacterial pyoderma from 1990 to 2019 and the forecast for the next decade
by: Hao Wang, et al.
Published: (2025-01-01)

Peripheral Ulcerative Keratitis with Pyoderma Gangrenosum
by: Adrián Imbernón-Moya, et al.
Published: (2015-01-01)

Pyoderma gangrenosum. A case report
by: Elizabet Fernández López, et al.
Published: (2023-02-01)

Successful Treatment of Annular Atrophic Lichen Planus With Adalimumab
by: Joe Khodeir, et al.
Published: (2025-01-01)

Size exclusion chromatography as green support for forced degradation study of adalimumab
by: Kovačić Jelena, et al.
Published: (2023-12-01)

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation
by: Chunbo Zhang, et al.
Published: (2025-01-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)

Pyoderma Gangrenosum in Two Successive Pregnancies Complicating Caesarean Wound
by: Sapna Vinit Amin, et al.
Published: (2014-01-01)

Erythema Nodosum and Pyoderma Gangrenosum in 50 Patients with Crohn’s Disease
by: Hugh J Freeman
Published: (2005-01-01)

Case report: dysgeusia, strawberry tongue, and psoriatic eruptions after combination treatment with adalimumab, sulfasalazine, and etoricoxib for ankylosing spondylitis
by: Binglin Cui, et al.
Published: (2025-02-01)

Pyoderma Gangrenosum Mimicking an Infected Wound following Dynamic Hip Screw Fixation
by: Metin Nizamoglu
Published: (2015-01-01)

Large Pyoderma Gangrenosum-Like Ulcers: A Rare Presentation of Granulomatosis with Polyangiitis
by: Basheer Tashtoush, et al.
Published: (2014-01-01)

Pyoderma Gangrenosum following Pacemaker Implantation: A Case Report and Review of Literature
by: Noura Ayoubi, et al.
Published: (2019-01-01)

Treatment Considerations for Pyoderma Gangrenosum After Reduction Mammoplasty in an Unsuspecting Patient Demographic
by: Natalia A. Pluta, MS, et al.
Published: (2025-01-01)

Pyoderma Gangrenosum and Autoimmune Chronic Active Hepatitis in a 17-Year-Old Female
by: Joanne M. Langley, et al.
Published: (1988-01-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
by: Stephen E. Langabeer, et al.
Published: (2015-01-01)

Pyoderma Gangrenosum: A Review of Clinical Features and Outcomes of 23 Cases Requiring Inpatient Management
by: Mingwei Joel Ye, et al.
Published: (2014-01-01)

Surgical site infection secondary to caesarean section: A case report of unrecognized pyoderma gangrenosum
by: Yanyan Tong, et al.
Published: (2025-02-01)

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
by: Shinri Sato, et al.
Published: (2025-01-01)

Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
by: Anna Pau, et al.
Published: (2025-01-01)

Staphylococcal skin infection isolates from dogs without recent antibiotic exposure are 100% susceptible to clindamycin
by: W. Cooper Brookshire, et al.
Published: (2025-02-01)

Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
by: Cilomar Martins De Oliveira Filho, et al.
Published: (2022-01-01)

Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
by: Dana Emerson, et al.
Published: (2025-02-01)

Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab
by: Efterpi Zafiriou, et al.
Published: (2025-01-01)

Treatment advances in Vitiligo: An Updated Review
by: Ishrat Binti Ismail, et al.
Published: (2025-01-01)

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report
by: M. A. Sobas, et al.
Published: (2017-01-01)

A Rare Co-Occurrence of Triple Mutations in JAK2, CALR, and MPL in the Same Patient with Myelofibrosis
by: Sherine J. Thomas, et al.
Published: (2022-01-01)

Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
by: Mi-Ae Lyu, et al.
Published: (2025-02-01)

Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma
by: Ravi Dhital, et al.
Published: (2025-03-01)

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
by: Nada Alghamdi, et al.
Published: (2025-01-01)

Activating Mutation (V617F) in the Tyrosine Kinase JAK2 is Absent in Locally-Confined or Castration-Resistant Prostate Cancer
by: Lei Gu, et al.
Published: (2010-01-01)